Julie Jordan - 07 Mar 2023 Form 3 Insider Report for Homology Medicines, Inc. (QTTB)

Role
Chief Medical Officer
Signature
/s/ Paul Alloway, Attorney-in-Fact for Julie Jordan
Issuer symbol
QTTB
Transactions as of
07 Mar 2023
Net transactions value
$0
Form type
3
Filing time
16 Mar 2023, 17:03:39 UTC
Next filing
04 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding FIXX Common Stock 2,519 07 Mar 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding FIXX Employee Stock Option (Right to Buy) 07 Mar 2023 Common Stock 65,000 $6.53 Direct F1
holding FIXX Employee Stock Option (Right to Buy) 07 Mar 2023 Common Stock 56,000 $2.71 Direct F2
holding FIXX Employee Stock Option (Right to Buy) 07 Mar 2023 Common Stock 9,000 $3.59 Direct F3
holding FIXX Employee Stock Option (Right to Buy) 07 Mar 2023 Common Stock 143,000 $1.60 Direct F4
holding FIXX Restricted Stock Units 07 Mar 2023 Common Stock 350 Direct F5, F6
holding FIXX Restricted Stock Units 07 Mar 2023 Common Stock 5,360 Direct F6, F7
holding FIXX Restricted Stock Units 07 Mar 2023 Common Stock 1,340 Direct F6, F8
holding FIXX Restricted Stock Units 07 Mar 2023 Common Stock 24,000 Direct F6, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests or has vested as to 25% of the underlying shares on May 3, 2022 and in 36 substantially equal monthly installments upon the Reporting Person's completion of each full month of service thereafter so that such option will become fully vested on May 3, 2025.
F2 The option vests in 48 substantially equal monthly installments upon the Reporting Person's completion of each full month of service following January 1, 2022 so that such option will become fully vested on January 1, 2026.
F3 The option vests in 48 substantially equal monthly installments upon the Reporting Person's completion of each full month of service following January 1, 2022 so that such option will become fully vested on January 1, 2026.
F4 The option vests in 48 substantially equal monthly installments upon the Reporting Person's completion of each full month of service following January 1, 2023 so that such option will become fully vested on January 1, 2027.
F5 The restricted stock units will vest and settle in full on August 2, 2023.
F6 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.
F7 The restricted stock units will vest and settle as to one half of the restricted stock units on each of January 1, 2024 and January 1, 2025.
F8 The restricted stock units will vest and settle as to one half of the restricted stock units on each of January 1, 2024 and January 1, 2025.
F9 The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2023 so that such RSUs will become fully vested on January 1, 2026.

Remarks:

Exhibit 24 - Power of Attorney.